Slider

5 Must-Know Insights into the Biopharmaceutical Manufacturing Market
5 Must-Know Insights into the Biopharmaceutical Manufacturing Market
The Biopharmaceutical Market Worldwide Will Be Worth Nearly One Trillion USD by 2030 The Global Biopharmaceutical Market is anticipated to be valued at almost $1 trillion USD by 2030 (As stated by Statista 2023). As chronic diseases like cancer, diabetes, and heart disease are becoming more prevalent around the world, there is a surge in...
by admin0
5 Biggest Challenges for the Market Research Pharmaceutical Industry In 2023
5 Biggest Challenges for the Market Research Pharmaceutical Industry In 2023
The biopharma industry has witnessed extensive growth in recent years due to the rising demand for drugs to treat and cure a wide range of diseases. The biopharma industry is changing how we identify and treat diseases thanks to developments in gene editing, biosensors, and other technologies. However, with this growth comes a plethora of...
by admin0
Real-Time Data, Development, and Analysis of Pharmaceutical Market Data
Real-Time Data, Development, and Analysis of Pharmaceutical Market Data
IMAPAC has a new comprehensive market intelligence tool to produce pharma and pharmaceutical market data in real-time. The visualization tool makes it possible to analyze historical and current data in real time in a matter of seconds instead of many hours. Apart from scalability, the data tool opens a spectrum of new analytical and reporting...
by admin0
Understanding Market Research in Pharmaceutical Industry : An Overview
Understanding Market Research in Pharmaceutical Industry : An Overview
With the increasing complexity of products, competition, regulations, and global markets, the need for comprehensive market intelligence has become increasingly essential in order to remain successful in the most rapidly expanding industry- Biopharmaceuticals. For biopharma companies, market research services are proving to be a valuable asset in product development. Companies conduct market research in pharmaceutical...
by admin0
Medigen applies for Australian vaccine approval
Medigen applies for Australian vaccine approval
Excerpt Medigen Vaccine Biologics Corp (高端疫苗) has applied to the Australian medicines regulator for provisional approval of its COVID-19 vaccine. Article Summary Medigen Vaccine Biologics Corp applied to Australian medicines regulator for provisional approval of the COVID-19 vaccine and has delivered the necessary documents to the Australian Therapeutic Goods Administration (TGA), but did not say...
by admin0
Prestige Biopharma announces International Non-proprietary Name for PBP1510
Prestige Biopharma announces International Non-proprietary Name for PBP1510
Excerpt Prestige Biopharma Limited, announced that its first-in-class antibody PBP1510 has acquired an International Nonproprietary Name (INN) of ‘Ulenistamab’ and was placed on the INN Recommended List by the World Health Organization (WHO). Article Summary Prestige Biopharma Limited first-in-class antibody has acquired an International Nonproprietary Name (INN) of ‘Ulenistamab’. INN-Ulenistamab, which is also known as...
by admin0